These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy. Sigsgaard T, Herrstedt J, Andersen LJ, Havsteen H, Langer SW, Kjaerbøl AG, Lund H, Kjaer M, Dombernowsky P. Br J Cancer; 1999 May; 80(3-4):412-8. PubMed ID: 10408847 [Abstract] [Full Text] [Related]
3. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy. Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429 [Abstract] [Full Text] [Related]
4. A double-blind comparison of the efficacy of two dose regimens of oral granisetron in preventing acute emesis in patients receiving moderately emetogenic chemotherapy. Ettinger DS, Eisenberg PD, Fitts D, Friedman C, Wilson-Lynch K, Yocom K. Cancer; 1996 Jul 01; 78(1):144-51. PubMed ID: 8646710 [Abstract] [Full Text] [Related]
5. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy. Burris H, Hesketh P, Cohn J, Moriconi W, Ryan T, Friedman C, Fitts D. Cancer J Sci Am; 1996 Jul 01; 2(2):85-90. PubMed ID: 9166505 [Abstract] [Full Text] [Related]
6. [Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord]. Huc P, Block S, Carlier D, Darloy F, Bonneterre ME, Bleuse JP, Fournier C, Bonneterre J. Bull Cancer; 1998 Jun 01; 85(6):562-8. PubMed ID: 9752283 [Abstract] [Full Text] [Related]
8. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy. Yeo W, Mo FK, Suen JJ, Ho WM, Chan SL, Lau W, Koh J, Yeung WK, Kwan WH, Lee KK, Mok TS, Poon AN, Lam KC, Hui EK, Zee B. Breast Cancer Res Treat; 2009 Feb 01; 113(3):529-35. PubMed ID: 18327706 [Abstract] [Full Text] [Related]
9. Efficacy of ondansetron tablets in the management of chemotherapy-induced emesis: review of clinical trials. Beck TM. Semin Oncol; 1992 Dec 01; 19(6 Suppl 15):20-5. PubMed ID: 1485178 [Abstract] [Full Text] [Related]
12. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma. Slabý J, Trnený M, Procházka B, Klener P. Neoplasma; 2000 Dec 01; 47(5):319-22. PubMed ID: 11130251 [Abstract] [Full Text] [Related]
13. [Value of the combination of oral ondansetron with methylprednisolone as soon as the first cure in mild emetogenic chemotherapy. Groupe français d'étude de l'ondansétron]. Coiffier B, Khayat D, Misset JL, Votan B. Bull Cancer; 1997 Aug 01; 84(8):781-7. PubMed ID: 9339181 [Abstract] [Full Text] [Related]
14. [Antiemetic efficacy of granisetron in repeated CAF chemotherapy after breast cancer operation]. Park Y, Hatano Y, Sasamoto S, Kato N, Okuyama N, Yamazaki S. Gan To Kagaku Ryoho; 1997 Mar 01; 24(5):573-7. PubMed ID: 9087290 [Abstract] [Full Text] [Related]
17. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy. Jones E, Koyama T, Ho RH, Kuttesch J, Shankar S, Whitlock JA, Cartwright J, Frangoul H. Pediatr Blood Cancer; 2007 Mar 01; 48(3):330-2. PubMed ID: 16304666 [Abstract] [Full Text] [Related]
20. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting. Hajdenberg J, Grote T, Yee L, Arevalo-Araujo R, Latimer LA. J Support Oncol; 2006 Oct 01; 4(9):467-71. PubMed ID: 17080735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]